Comtesse Hannah, Vogel Anna, Kersting Anette, Rief Winfried, Steil Regina, Rosner Rita
Department of Clinical and Biological Psychology, Catholic University Eichstaett-Ingolstadt, Germany.
Department of Psychosomatic Medicine, University of Leipzig, Leipzig, Germany.
Eur J Psychotraumatol. 2020 Jan 8;11(1):1694348. doi: 10.1080/20008198.2019.1694348. eCollection 2020.
: Prolonged grief disorder (PGD) will be newly included in the ICD-11, while a clinically similar diagnosis, persistent complex bereavement disorder (PCBD), has already been added to the DSM-5. Only few studies have evaluated these criteria-sets for prolonged grief. : The aim of this study was to evaluate the ICD-11 accessory symptom threshold and compare the diagnostic performance of the two criteria-sets in treatment-seeking bereaved persons. : 113 grief treatment-seeking bereaved persons completed the Interview for Prolonged Grief-13. We used receiver operator characteristic analysis to determine an optimum ICD-11 accessory symptom threshold. We calculated diagnostic rates for PGD and PCBD and examined associations of PGD and PCBD caseness with concurrently assessed psychopathology and prolonged grief symptoms assessed one month later. : An ICD-11 threshold of six accessory symptoms distinguished optimally between interview-diagnosed participants with and without prolonged grief. The prevalence of PGD (69%) was significantly higher than that of PCBD (48%) and of PGD with a 6-symptom threshold (47%). PGD caseness was associated with the relation to the deceased, 6-symptom threshold PGD and PCBD caseness with the time since loss. All criteria-sets were linked to concurrent prolonged grief, depression, and general mental distress. PCBD and 6-symptom threshold PGD but not PGD were associated with prolonged grief severity one month later. : The results support the validity of PGD and PCBD but, at the same time, they provide further support for differing prevalence rates. Using an empirically determined ICD-11 accessory symptom threshold could prevent the pathologisation of grief reactions.
持续性悲伤障碍(PGD)将被新纳入《国际疾病分类第11版》(ICD - 11),而一种临床相似的诊断——持续性复杂丧亲之痛障碍(PCBD)已被添加到《精神疾病诊断与统计手册第5版》(DSM - 5)中。仅有少数研究评估了这些针对持续性悲伤的标准集。本研究的目的是评估ICD - 11的附加症状阈值,并比较这两种标准集在寻求治疗的丧亲者中的诊断性能。113名寻求悲伤治疗的丧亲者完成了《持续性悲伤访谈 - 13》。我们使用接受者操作特征分析来确定最佳的ICD - 11附加症状阈值。我们计算了PGD和PCBD的诊断率,并检查了PGD和PCBD病例与同时评估的精神病理学以及一个月后评估的持续性悲伤症状之间的关联。ICD - 11的六个附加症状阈值能最佳地区分访谈诊断出的有或没有持续性悲伤的参与者。PGD的患病率(69%)显著高于PCBD的患病率(48%)以及具有六个症状阈值的PGD的患病率(47%)。PGD病例与与逝者的关系有关,具有六个症状阈值时PGD和PCBD病例与丧亲后的时间有关。所有标准集都与同时存在的持续性悲伤、抑郁和一般精神困扰有关。PCBD和具有六个症状阈值的PGD(但不是PGD本身)与一个月后的持续性悲伤严重程度有关。这些结果支持了PGD和PCBD的有效性,但同时也为不同的患病率提供了进一步支持。使用根据经验确定的ICD - 11附加症状阈值可以防止悲伤反应被病理化。